genOway Société anonyme (FRA:JEH)

Market Cap	22.41M -31.2%
Revenue (ttm)	27.16M -3.3%
Net Income	1.29M +2.5%
EPS	n/a
Shares Out	n/a
PE Ratio	17.41
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	2.330
Previous Close	2.340
Day's Range	2.330 - 2.330
52-Week Range	2.030 - 3.440
Beta	n/a
RSI	55.95
Earnings Date	Apr 2, 2026

About genOway Société anonyme

genOway Société anonyme, a biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line models worldwide. It produces customized mouse models, such as knockout (KO) and knockin (KI) mouse models; customized rat models, including constitutive and conditional KO, point mutation KI, and quick KI rat models; and customized cell lines, such as constitutive and inducible KO, point mutation KI, reporter KI, quick KI, and KI cell lines. The company also offers humanized immune checkpoi...

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 1999
• Employees: 148
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: JEH

Financial Performance

In 2024, genOway Société anonyme's revenue was 27.53 million, an increase of 3.85% compared to the previous year's 26.51 million. Earnings were 1.83 million, an increase of 16.79%.